協和キリンの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2014/05/26 | 1,253 | 1,254 | 1,236 | 1,254 | +4 | +0.3% | 642,000 |
| 2014/05/23 | 1,242 | 1,253 | 1,241 | 1,250 | +17 | +1.4% | 769,000 |
| 2014/05/22 | 1,215 | 1,236 | 1,209 | 1,233 | +28 | +2.3% | 1,091,000 |
| 2014/05/21 | 1,189 | 1,210 | 1,189 | 1,205 | -1 | -0.1% | 685,000 |
| 2014/05/20 | 1,198 | 1,213 | 1,194 | 1,206 | +8 | +0.7% | 729,000 |
| 2014/05/19 | 1,183 | 1,205 | 1,183 | 1,198 | +17 | +1.4% | 835,000 |
| 2014/05/16 | 1,176 | 1,190 | 1,168 | 1,181 | -18 | -1.5% | 1,070,000 |
| 2014/05/15 | 1,200 | 1,202 | 1,181 | 1,199 | -11 | -0.9% | 755,000 |
| 2014/05/14 | 1,209 | 1,210 | 1,198 | 1,210 | +5 | +0.4% | 597,000 |
| 2014/05/13 | 1,210 | 1,217 | 1,200 | 1,205 | +11 | +0.9% | 1,181,000 |
| 2014/05/12 | 1,184 | 1,197 | 1,183 | 1,194 | +6 | +0.5% | 839,000 |
| 2014/05/09 | 1,183 | 1,192 | 1,178 | 1,188 | +4 | +0.3% | 1,115,000 |
| 2014/05/08 | 1,169 | 1,188 | 1,162 | 1,184 | +30 | +2.6% | 984,000 |
| 2014/05/07 | 1,151 | 1,165 | 1,148 | 1,154 | -25 | -2.1% | 1,273,000 |
| 2014/05/02 | 1,172 | 1,188 | 1,171 | 1,179 | +7 | +0.6% | 737,000 |
| 2014/05/01 | 1,152 | 1,174 | 1,152 | 1,172 | +8 | +0.7% | 851,000 |
| 2014/04/30 | 1,178 | 1,179 | 1,161 | 1,164 | -1 | -0.1% | 1,159,000 |
| 2014/04/28 | 1,168 | 1,169 | 1,152 | 1,165 | -7 | -0.6% | 897,000 |
| 2014/04/25 | 1,169 | 1,186 | 1,163 | 1,172 | +17 | +1.5% | 1,156,000 |
| 2014/04/24 | 1,160 | 1,162 | 1,150 | 1,155 | +1 | +0.1% | 658,000 |
| 2014/04/23 | 1,151 | 1,159 | 1,147 | 1,154 | +9 | +0.8% | 849,000 |
| 2014/04/22 | 1,157 | 1,163 | 1,145 | 1,145 | -5 | -0.4% | 739,000 |
| 2014/04/21 | 1,154 | 1,159 | 1,146 | 1,150 | ±0 | ±0% | 647,000 |
| 2014/04/18 | 1,145 | 1,151 | 1,140 | 1,150 | +5 | +0.4% | 694,000 |
| 2014/04/17 | 1,127 | 1,153 | 1,127 | 1,145 | +38 | +3.4% | 1,847,000 |
| 2014/04/16 | 1,085 | 1,112 | 1,085 | 1,107 | +28 | +2.6% | 1,256,000 |
| 2014/04/15 | 1,084 | 1,086 | 1,074 | 1,079 | +15 | +1.4% | 946,000 |
| 2014/04/14 | 1,061 | 1,082 | 1,060 | 1,064 | +4 | +0.4% | 1,187,000 |
| 2014/04/11 | 1,070 | 1,077 | 1,058 | 1,060 | -24 | -2.2% | 2,215,000 |
| 2014/04/10 | 1,085 | 1,089 | 1,071 | 1,084 | +16 | +1.5% | 1,488,000 |
| 2014/04/09 | 1,059 | 1,070 | 1,057 | 1,068 | -4 | -0.4% | 1,658,000 |
| 2014/04/08 | 1,080 | 1,080 | 1,057 | 1,072 | -15 | -1.4% | 1,362,000 |
| 2014/04/07 | 1,085 | 1,094 | 1,081 | 1,087 | -3 | -0.3% | 767,000 |
| 2014/04/04 | 1,085 | 1,090 | 1,075 | 1,090 | -9 | -0.8% | 1,132,000 |
| 2014/04/03 | 1,091 | 1,104 | 1,087 | 1,099 | +8 | +0.7% | 757,000 |
| 2014/04/02 | 1,097 | 1,100 | 1,085 | 1,091 | +13 | +1.2% | 1,293,000 |
| 2014/04/01 | 1,098 | 1,099 | 1,076 | 1,078 | -22 | -2% | 1,309,000 |
| 2014/03/31 | 1,097 | 1,103 | 1,085 | 1,100 | +3 | +0.3% | 976,000 |
| 2014/03/28 | 1,093 | 1,105 | 1,088 | 1,097 | +11 | +1% | 1,295,000 |
| 2014/03/27 | 1,064 | 1,089 | 1,064 | 1,086 | +32 | +3% | 2,092,000 |
| 2014/03/26 | 1,073 | 1,075 | 1,048 | 1,054 | +1 | +0.1% | 1,704,000 |
| 2014/03/25 | 1,050 | 1,073 | 1,046 | 1,053 | +9 | +0.9% | 1,645,000 |
| 2014/03/24 | 1,014 | 1,067 | 1,014 | 1,044 | +38 | +3.8% | 1,802,000 |
| 2014/03/20 | 1,024 | 1,029 | 1,006 | 1,006 | -23 | -2.2% | 963,000 |
| 2014/03/19 | 1,026 | 1,042 | 1,015 | 1,029 | +5 | +0.5% | 1,117,000 |
| 2014/03/18 | 1,021 | 1,036 | 1,020 | 1,024 | +11 | +1.1% | 803,000 |
| 2014/03/17 | 1,013 | 1,029 | 1,011 | 1,013 | -10 | -1% | 917,000 |
| 2014/03/14 | 1,040 | 1,048 | 1,020 | 1,023 | -45 | -4.2% | 2,949,000 |
| 2014/03/13 | 1,067 | 1,078 | 1,066 | 1,068 | -1 | -0.1% | 694,000 |
| 2014/03/12 | 1,089 | 1,091 | 1,069 | 1,069 | -37 | -3.3% | 978,000 |
2751～
2800
件表示中 / 3768件
類似銘柄と比較する
現在ご覧いただいている「協和キリン」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 協和キリン | 263,900円 | -3.5% | -11.3% | 2.27% | 24.24倍 | 1.65倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
| アステラス薬 | 169,200円 | +0.9% | +380.2% | 4.61% | 23.31倍 | 2.01倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
| 塩野義 | 258,000円 | +20.9% | +10.6% | 2.56% | 12.19倍 | 1.61倍 |
|
抗ＨＩＶ薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
| エーザイ | 467,600円 | +0.1% | -3.4% | 3.42% | 31.79倍 | 1.56倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
| 小野薬 | 166,100円 | +0.6% | +43.3% | 4.82% | 11.65倍 | 1.00倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
市場注目の銘柄
チャート関連のコラム
